Research with human participants

Overview of medical research in the Netherlands

Effect of brimonidine, measured with the Nerve Fibre Analyser, in patients with acute ischaemic optic neuropathy.

No registrations found.

Download: PDF | XML
Ethical review
Positive opinion
Status
Recruitment stopped
Health condition type
-
Study type
Interventional

ID

NL-OMON22790

Source

NTR

Brief title

AION

Intervention

Outcome measures

Primary outcome

Thickness of peripapillary nerve fiber layer.

Secondary outcome

N/A

Background summary

N/A

Study objective

Administration of brimonidine eye drops in patients with AION reduces loss of vision.

Study design

N/A

Intervention

Topical treatment with Brimonidine (0.5%) eye drops.

Public
Oogziekenhuis Rotterdam,
Schiedamsevest 180
H.G. Lemij
Schiedamsevest 180
Rotterdam 3011 BH
The Netherlands
+31 (0)10 4017777
Lemij@oogziekenhuis.nl
Scientific
Oogziekenhuis Rotterdam,
Schiedamsevest 180
H.G. Lemij
Schiedamsevest 180
Rotterdam 3011 BH
The Netherlands
+31 (0)10 4017777
Lemij@oogziekenhuis.nl

Inclusion criteria

Arteric or non-arteric AION.

Exclusion criteria

1. Onset of symptoms > 5 days ago at presentation;

2. Inability to undergo GDx or HFA measurement.

Design

Study type :
Interventional
Intervention model
:
Parallel
Allocation :
Randomized controlled trial
Masking :
Double blinded (masking used)
Control :
Placebo

Recruitment

NL
Recruitment status
:
Recruitment stopped
Start date (anticipated) :
Enrollment :
20
Type :
Actual

Positive opinion
Date :
Application type :
First submission

Followed up by the following (possibly more current) registration

No registrations found.

Other (possibly less up-to-date) registrations in this register

No registrations found.

In other registers

Register ID
NTR-new NL108
NTR-old NTR139
Other : OZR-2000-07
ISRCTN ISRCTN58221074

Summary results

N/A